Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 051530/0653 | |
| Pages: | 21 |
| | Recorded: | 01/16/2020 | | |
| Conveyance: | MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/20/2013
|
Application #:
|
13121804
|
Filing Dt:
|
03/30/2011
|
|
Publication #:
|
|
Pub Dt:
|
07/28/2011
| | | | |
|
Title:
|
Treatment of Mood and Anxiety Disorders
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/03/2019
|
Application #:
|
15049825
|
Filing Dt:
|
02/22/2016
|
|
Publication #:
|
|
Pub Dt:
|
08/25/2016
| | | | |
|
Title:
|
Inhibitor Peptides of ERK-type MAP kinase
|
|
|
Assignor
|
|
|
|
|
|
Newly Merged Entity Data
|
|
|
|
|
|
Newly Merged Entity's New Name
|
|
|
|
|
| 21 RUE DE L'ÉCOLE DE MÉDECINE |
| PARIS, FRANCE 75006 |
|
|
Correspondence name and address
|
| |
FRANK C. EISENSCHENK, PH.D.
|
| |
P.O. BOX 142950
|
| |
GAINESVILLE, FL 32614-2950
|
Search Results as of:
04/29/2024 03:28 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
